These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia. Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034 [TBL] [Abstract][Full Text] [Related]
15. Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients. Kim HS; Youn T; Kim SH; Jeong SH; Jung HY; Jeong SW; Kim KK; Kim YS; Chung IW Int Clin Psychopharmacol; 2019 May; 34(3):131-137. PubMed ID: 30855515 [TBL] [Abstract][Full Text] [Related]
16. EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia. Knott V; Labelle A; Jones B; Mahoney C Clin Electroencephalogr; 2000 Jul; 31(3):145-52. PubMed ID: 10923202 [TBL] [Abstract][Full Text] [Related]
17. A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients. Chung SJ; Jeong SH; Ahn YM; Kang UG; Koo YJ; Ha JH; Lee SG; Kim YS Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):139-44. PubMed ID: 11853104 [TBL] [Abstract][Full Text] [Related]
18. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
20. Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia. Fabrazzo M; La Pia S; Monteleone P; Esposito G; Pinto A; De Simone L; Bencivenga R; Maj M Neuropsychopharmacology; 2002 Dec; 27(6):1050-5. PubMed ID: 12464462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]